With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This...
With the approval of the first anti-amyloid antibodies, lecanemab and donanemab, the therapeutic landscape for Alzheimer disease has entered a new era—one that presents both promise and complexity. This...
Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint. In...
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint. In...
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint. In...
